Filter By:

Binimetinib

04/20/2010

American Association for Cancer Research Annual Meeting

Investigation of the growth inhibitory activity of the MEK inhibitor ARRY-438162 in combination with everolimus in a variety of KRas and P13K pathway mutant cancers

B.J. Tunquist, et al.

Binimetinib

04/19/2010

American Association for Cancer Research Annual Meeting

ARRY-162, A Potent and Selective MEK 1 / 2 Inhibitor, Shows Enhanced Efficacy in Combination with Other Targeted Kinase Inhibitors and with Chemotherapy

R. Woessner, et al.

Binimetinib

04/19/2010

American Association for Cancer Research Annual Meeting

Preclinical Development of ARRY-162, A Potent and Selective MEK 1 / 2 Inhibitor

P. Lee, Ph.D., et al.

ARRY-502

02/27/2010

American Academy of Allergy, Asthma & Immunology Annual Meeting

Potent and Selective CRTh2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis and Atopic Dermatitis

L. L. Carter, et al.